The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. - sprookjes - yvandenbroek - TriplyDB

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

http://www.wikidata.org/entity/Q34061794

about

18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 The Alzheimer's Disease Neuroimaging Initiative informatics core: A decade in review The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015 Brain imaging in Alzheimer disease HDL and glucose metabolism: current evidence and therapeutic potential The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Development of positron emission tomography β-amyloid plaque imaging agents Neuroimaging biomarkers of neurodegenerative diseases and dementia Imago Mundi, Imago AD, Imago ADNI The clinical value of large neuroimaging data sets in Alzheimer's disease APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers In vivo assessment of amyloid-β deposition in nondemented very elderly subjects Amyloid imaging in dementias with atypical presentation.The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies.Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Brain imaging in dementia.Brain imaging of neurovascular dysfunction in Alzheimer's disease.Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI Amyloid burden and neural function in people at risk for Alzheimer's Disease.Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography.Quantitative structural MRI for early detection of Alzheimer's disease.Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series.Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease.Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.Homeostatic disinhibition in the aging brain and Alzheimer's disease Positive affect predicts cerebral glucose metabolism in late middle-aged adults.Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data.Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's disease Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications.Multi-Channel neurodegenerative pattern analysis and its application in Alzheimer's disease characterization.Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Transcriptome-guided amyloid imaging genetic analysis via a novel structured sparse learning algorithm A statistical parametric mapping toolbox used for voxel-wise analysis of FDG-PET images of rat brain

P2860

Q24186399-F89972E2-6994-4229-A155-B80B8D02C395 Q26801629-70640699-DD06-414E-9208-F0EEA2495B97 Q26801637-53470C74-12D4-47E0-B593-23C200E84E9D Q26801654-0B08CF20-61B8-45B7-8749-1012F6705E60 Q26996299-C3322432-F423-4D08-8F9E-B2B816CE80B6 Q26996502-B446368D-CBF4-4A4C-8C33-CD83D723FD1D Q27006831-ADED479C-DDC7-4407-8643-07D16CAC67E5 Q27012742-EC06C61F-D9B7-4B7B-AAF3-AA6F11C51D89 Q27691820-0C207E9B-A01E-4A2D-9B4D-A3190BE120B6 Q28650395-6F2A6CD7-015B-4BBD-82CA-64BA80C89CBE Q28709465-BF57DC4C-5255-425C-BA0B-EA78AFF2D18A Q29416986-440FE3A9-9AF2-437E-A1AC-512DB30DD713 Q29620245-5E570CF3-9CBD-45EF-A0B3-DD4A7004A68B Q30412704-0E6F941C-A873-44B9-AAED-FDF800785825 Q30417342-EE82B4FB-9FD5-4F53-8027-73CA8CAD6D7D Q30830414-D202E456-4D6F-4AF8-858A-E8BCA7B4054F Q30871982-91FCDBFC-859B-4E8A-8C8C-FE9D2DFE8484 Q30971403-D296AEFB-0DF3-431F-967B-47B00670B41D Q31051218-721F29CD-3AAE-4E2C-A515-0C208103948F Q31066988-D9A61F82-2FE6-408C-8B37-4D9B12F5F903 Q31096423-6E6B6E94-1D1D-4D25-9CE2-A4D5F00FB91F Q31109560-6FBFC7F1-09CE-4F96-BE97-F7B552913D75 Q31110973-5F624407-F66B-4F4F-B31E-843232CCD537 Q33599047-FD621DF6-6C83-4CB8-BD9A-0ED00F8D96A5 Q33695122-0B7A1A0B-14DB-4E0C-9789-AB2EFE383989 Q33709603-165C24EE-FE2E-4BED-B33E-89A8A8BB8302 Q33729033-7027249E-ABBA-4493-B22F-E5A601F0886F Q33758587-A612D257-FFBB-49B6-9889-5773617C1813 Q33764303-C39F2667-ED3B-4B39-8A52-569B957CAD1A Q33770976-A90BD931-9C75-4E34-A741-10B86BF9D4CA Q33780879-3C7BFA51-2806-4409-983D-206590950A5E Q33802786-2DEDEC11-438E-49EB-8527-6586706E3C5D Q33816135-15FBB8CA-7F90-4FF7-8B87-0A0D2C67BADF Q33920450-6A15899E-7A4A-47CD-8BEB-A203A01802C7 Q33968419-D8CF387E-AB11-42C9-8418-728CB2D6FD60 Q34053888-0A62358F-0D2B-465F-B335-6A35697BC85E Q34054198-7BA9E58E-0B56-49BC-BE0E-ED67723B38EB Q34065449-73812FD6-08B5-42C2-BDCE-13639DF5C3EC Q34103206-D885C605-64A7-45E2-B596-245BCD4FF025 Q34258517-F7A9430A-39E7-4AFD-88B1-1AE7C568BA38

P2860

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

http://www.wikidata.org/entity/Q34061794

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

@ast

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

@en

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

@nl

type

label

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

@ast

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

@en

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

@nl

prefLabel

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

@ast

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

@en

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

@nl

P1433

Q34061794-6FCA412E-D8BB-447E-9BE7-D2E5E14924E4

P1476

Q34061794-FE6B687F-8986-42F8-A64E-CF5D3B405DB5

P2093

Q34061794-04615055-EC3B-442E-AAC4-CEF19483C427

Q34061794-27B2CC29-A1BF-4D1A-8CAE-5184BA0E5F8B

Q34061794-6CFE50FB-F851-4DFE-940C-2558841CC591

Q34061794-8F4A0083-B07B-49E0-B0DB-0C195D751918

Q34061794-B8F47F33-D493-4D9E-85C0-3F3CED383CCE

Q34061794-D1ADB3A6-F3F1-4CBF-8C2A-E5CEFFF1FCD7

Q34061794-E46F89BC-4644-4ABB-A384-054A878AB997

Q34061794-EA12A47A-2C4E-4843-A9B1-BD3BEE5A338F

P2860

Q34061794-017D7CB5-C28F-4F3C-B006-ACE886586ED3

Q34061794-04A3EDEE-BFFD-4E42-94D4-6A7CED00CC14

Q34061794-16CD5F89-C70A-4F87-A710-3290940010F1

Q34061794-18464936-F444-4D46-9505-0E27372B0E6A

Q34061794-4034CE5A-E8CE-475C-85E2-56C43CD95482

Q34061794-54D27A8B-A1E2-4E35-B192-C3E497497882

Q34061794-5CBF1305-4AB9-42A3-9800-5DB97330AD6F

Q34061794-65A5E427-DA24-49AB-8DC6-43B374584B43

Q34061794-863B0B3A-603D-4BCF-9D02-A2AE71814178

Q34061794-8F59BE63-E83E-40CC-8C4C-507B9EF879BA

P304

Q34061794-EED876F0-EFAD-4252-80CE-DECBAF36F93E

P31

Q34061794-3BDFC4D4-3450-4CA6-90A2-532CF0978C77

P356

Q34061794-2ACF60CA-3E7F-4E35-98F1-EFA122B9FF88

P433

Q34061794-18028600-3E30-41D3-90FE-FA1C487E83C1

P478

Q34061794-3581A24B-0AF2-48BA-A446-5195C7790244

P50

Q34061794-49B02196-0C89-499B-B96A-2E8E9CA17767

Q34061794-4C96C7A5-A553-4FAE-B301-7C944745D0A7

Q34061794-83A4DD12-4531-48D3-A5CC-BD7CC5CCC9D1

P577

Q34061794-47C44028-9F6E-4BA1-8471-3169DCC48962

P5875

Q34061794-187966A5-5F4E-4F3E-A0C7-542DB3672C8F

P698

Q34061794-7D9B9FDA-CFA0-4B72-ADAC-87A050430E11

P921

Q34061794-33F352A8-604D-4E7B-A147-26CC5B23ABD0

Q34061794-3C277854-835E-48E5-99A9-46D723FAEF04

P932

Q34061794-9C2C4C22-9863-424B-A9EB-2A0F7AE2801E

P356

J.JALZ.2010.03.003

P1433

Alzheimer's and Dementia

P1476

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

@en

P2093

Chester A Mathis

http://www.w3.org/2001/XMLSchema#string

Dan Bandy

http://www.w3.org/2001/XMLSchema#string

Daniel Skovronsky

http://www.w3.org/2001/XMLSchema#string

Julie C Price

http://www.w3.org/2001/XMLSchema#string

Norman L Foster

http://www.w3.org/2001/XMLSchema#string

Robert A Koeppe

http://www.w3.org/2001/XMLSchema#string

Susan M Landau

http://www.w3.org/2001/XMLSchema#string

William J Jagust

http://www.w3.org/2001/XMLSchema#string

P2860

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects

Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.

Reducing between scanner differences in multi-center PET studies.

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

Frequent amyloid deposition without significant cognitive impairment among the elderly.

P304

221-229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JALZ.2010.03.003

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Alzheimer's Disease Neuroimaging Initiative

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44581956

http://www.w3.org/2001/XMLSchema#string

P698

20451870

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's Disease Neuroimaging Initiative

P932

2920531

http://www.w3.org/2001/XMLSchema#string